Drug Approval | May 12, 2023
USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
The Awards recognizes standout digital health & medical technology products and companies
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
The partnership will capitalize on the combined capabilities of the two organizations
Apollo continues to invest in genomics technology and research for better patient care
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Subscribe To Our Newsletter & Stay Updated
